Disrupting the expression of key enzymes in cholesterol biosynthesis, such as HMGCR and SQLE, appears to prevent carcinogenesis mechanisms in colorectal, breast, prostate and NAFLD-HCC cancers [18–22]. Here, SQLE is linked to hepatocellular carcinoma.